Drug Type ASO |
Synonyms |
Target- |
Mechanism RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Biorchestra Co., Ltd.Startup |
Active Organization Biorchestra Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Preclinical | KR | Biorchestra Co., Ltd.Startup | 12 Jun 2024 |
Amyotrophic Lateral Sclerosis | Preclinical | KR | Biorchestra Co., Ltd.Startup | - |